Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000629320 | SCV000750255 | pathogenic | Primary ciliary dyskinesia | 2023-02-14 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 525269). For these reasons, this variant has been classified as Pathogenic. This premature translational stop signal has been observed in individual(s) with primary ciliary dyskinesia (PMID: 23993197, 31130284). This variant is present in population databases (rs756868889, gnomAD 0.006%). This sequence change creates a premature translational stop signal (p.Gln144*) in the RSPH4A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RSPH4A are known to be pathogenic (PMID: 19200523). |
Illumina Laboratory Services, |
RCV000778772 | SCV000915141 | uncertain significance | Primary ciliary dyskinesia 11 | 2019-01-11 | criteria provided, single submitter | clinical testing | The RSPH4A c.430C>T (p.Gln144Ter) variant is a stop-gained variant that is predicted to result in a premature termination of the protein. The p.Gln144Ter variant has been reported in a heterozygous state in one individual affected with primary ciliary dyskinesia (Kott et al. 2013). The variant is found at a frequency of 0.000012 in the Total population of the Genome Aggregation Database. Due to the potential impact of stop-gained variants and the lack of clarifying evidence, the p.Gln144Ter variant is classified as a variant of unknown significance but suspicious for pathogenicity for primary ciliary dyskinesia. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. |
Center for Genomic Medicine, |
RCV000778772 | SCV004804712 | pathogenic | Primary ciliary dyskinesia 11 | 2024-03-17 | criteria provided, single submitter | research |